GlassScriptPhysician profile
Deborah K Scheuerell
NPI 1417055807
$1,751.96
in general payments reported to CMS, 2019-2025
16 companies · $58.14 in 2025
The $58.14 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $158 · 2022: $633 · 2023: $88.93 · 2024: $814 · 2025: $58.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $961.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $960.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $326.94 | 2021-2023 | Immunocap |
| Astrazeneca Pharmaceuticals LP | $264.93 | 2024 | Airsupra, Farxiga |
| Novo Nordisk INC | $240.04 | 2022 | |
| Aspira Women'S Health INC | $151.84 | 2024 | Ova1 |
| Amgen INC. | $140.82 | 2024 | Repatha |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2022 | |
| Aimmune Therapeutics, INC. | $124.98 | 2024 | |
| Lilly USA, LLC | $79.20 | 2022-2025 | Zepbound, Mounjaro |
| Glaxosmithkline, LLC. | $67.16 | 2024-2025 | Bexsero, Shingrix, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.84 | 2022 | |
| Merck Sharp & Dohme LLC | $61.39 | 2022-2023 | Gardasil 9, Pneumovax 23, M-M-R II |
| Exact Sciences Corporation | $32.01 | 2023-2025 | Cologuard Collection Kit |
| Redhill Biopharma INC. | $21.79 | 2024 | Talicia |
| Sanofi Pasteur INC. | $19.18 | 2023 | |
| Astellas Pharma US INC | $17.86 | 2024 | Veozah |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $15.98 | 2024 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Scheuerell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.